Drug intelligence / Profile preview

1-epilupinine

Development stage
Preclinical
Modality
Small Molecules
01

Overview

1-Epilupinine (ELP) is a quinolizidine alkaloid and a stereoisomer of lupinine, primarily found in plants of the genus *Lupinus*. It is currently being investigated for its potential therapeutic application in early-stage dementia and neurodegenerative diseases. Preclinical research indicates that 1-epilupinine possesses neuroprotective and anti-inflammatory properties, demonstrated by its ability to reverse cognitive deficits and reduce the expression of pro-inflammatory cytokines, including Granulocyte-macrophage colony-stimulating factor (GM-CSF), Interferon gamma (IFN-γ), Interleukin-2 (IL-2), and Interleukin-23 (IL-23), in the prefrontal cortex of scopolamine-induced dementia mouse models. Notably, the compound appears to improve cognitive function without adversely affecting motor activity or anxiety levels.

Other names
1-EpilupinineELPepilupinine
02

Targets

IL-2 (Interleukin 2)IFNG (Interferon gamma)IL-23 (Interleukin-23)GM-CSF (Granulocyte-macrophage colony-stimulating factor)

Beyond the preview

Go deeper on 1-epilupinine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1-epilupinine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call